Literature DB >> 32949624

Repeated radon exposure induced lung injury and epithelial-mesenchymal transition through the PI3K/AKT/mTOR pathway in human bronchial epithelial cells and mice.

Huiqin Chen1, Na Chen1, Fengsheng Li2, Liang Sun1, Jicong Du3, Yuanyuan Chen3, Fei Cheng2, Yanqing Li1, Siqi Tian1, Qisheng Jiang2, Fengmei Cui4, Yu Tu5.   

Abstract

Radon exposure is the most frequent cause of lung cancer in non-smokers. The high linear energy transfer alpha-particles from radon decay cause the accumulation of multiple genetic changes and lead to cancer development. Epithelial-mesenchymal transition (EMT) plays an important role in oncogenesis. However, the mechanisms underlying chronic radon exposure-induced EMT attributed to carcinogenesis are not understood. This study aimed to explore the EMT and potential molecular mechanisms induced by repeated radon exposure. The EMT model of 16HBE and BEAS-2B cells was established with radon exposure (20000 Bq/m3, 20 min each time every 3 days). We found repeated radon exposure facilitated epithelial cell migration, proliferation, reduced cell adhesion and ability to undergo EMT through a decrease in epithelial markers and an increase in mesenchymal markers. Radon regulated the expression of matrix metalloproteinase 2 (MMP2) and tissue inhibitors of metalloproteinase 2 (TIMP2) to disrupt the balance of MMP2/TIMP2. In vivo, BALB/c mice were exposed to 105 Bq/m3 radon gas for cumulative doses of 60 and 120 Working Level Months (WLM). Radon inhalation caused lung damage and fibrosis in mice, which was aggravated with the increase of exposure dose. EMT-like transformation also occurred in lung tissues of radon-exposure mice. Moreover, radon radiation increased p-PI3K, p-AKT and p-mTOR in cells and mice. Radon reduced the GSK-3β level and elevated the active β-catenin in 16HBE cells. The m-TOR and AKT inhibitors attenuated radon exposure-induced EMT by regulation related biomarkers. These data demonstrated that radon exposure induced EMT through the PI3K/AKT/mTOR pathway in epithelial cells and lung tissue.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  EMT; PI3K/AKT/mTOR; Radon exposure; The epithelial cells

Mesh:

Substances:

Year:  2020        PMID: 32949624     DOI: 10.1016/j.toxlet.2020.09.008

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  6 in total

1.  Prediction of the Mechanism of Sodium Butyrate against Radiation-Induced Lung Injury in Non-Small Cell Lung Cancer Based on Network Pharmacology and Molecular Dynamic Simulations and Molecular Dynamic Simulations.

Authors:  Xiao-Zhen Zhang; Mao-Jian Chen; Ping-Ming Fan; Ting-Shi Su; Shi-Xiong Liang; Wei Jiang
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

2.  Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway.

Authors:  Lili Song; Shikai Liu; Sufen Zhao
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

3.  Mouse mesenchymal stem cell-derived exosomal miR-466f-3p reverses EMT process through inhibiting AKT/GSK3β pathway via c-MET in radiation-induced lung injury.

Authors:  Yi Li; Zhufu Shen; Xiao Jiang; Yuanyuan Wang; Zuozhang Yang; Yuchi Mao; Zhixian Wu; Gaofeng Li; Hong Chen
Journal:  J Exp Clin Cancer Res       Date:  2022-04-07

4.  Proteomic and miRNA profiling of radon-induced skin damage in mice: FASN regulated by miRNAs.

Authors:  Wei Mo; Wanglei Xu; Min Hong; Tingyi Yang; Yuhong Shi; Yang Jiao; Jihua Nie; Fengmei Cui; Jianping Cao; Shuyu Zhang
Journal:  J Radiat Res       Date:  2022-09-21       Impact factor: 2.438

5.  Effects of GLP-1 Receptor Agonists on Biological Behavior of Colorectal Cancer Cells by Regulating PI3K/AKT/mTOR Signaling Pathway.

Authors:  Guoxiang Tong; Tianhao Peng; Ya Chen; Lijuan Sha; Huikang Dai; Yidong Xiang; Zhiqi Zou; Heli He; Sha Wang
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

6.  Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19.

Authors:  Qi-Dong Xia; Yang Xun; Jun-Lin Lu; Yu-Chao Lu; Yuan-Yuan Yang; Peng Zhou; Jia Hu; Cong Li; Shao-Gang Wang
Journal:  Cell Prolif       Date:  2020-11-03       Impact factor: 6.831

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.